Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results
– Conference Call Today at 4:30 p.m. ET – SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to...
– Conference Call Today at 4:30 p.m. ET – SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to...
Fourth quarter 2019 bookings of $312 million, up 6% year-over-year Extended Allscripts Managed Services Agreement with Northwell Health through 2026...
LAS VEGAS, March 2, 2020 /PRNewswire/ -- A Conversation with the Women of Steinberg Diagnostic Medical Imaging (SDMI) is an influential...
Joins as the Company Holds Second-Closing on Series A Funding, Gearing Up for Significant Growth BOULDER, CO / ACCESSWIRE /...
CHICAGO, IL / ACCESSWIRE / March 2, 2020 / Dear Members of Congress, FDA Commissioner, and HHS Secretary, I received...
Campaign supports national goals of increased kidney disease awareness and prevention ROCKVILLE, MD / ACCESSWIRE / March 2, 2020 /...
VANCOUVER, BC / ACCESSWIRE / March 2, 2020 / Mota Ventures Corp. (CSE: MOTA FSE: 1WZ:GR OTC: PEMTF) (the "Company"...
MALVERN, PA / ACCESSWIRE / March 2, 2020 / Virpax® Pharmaceuticals Inc. ("Virpax"), a company specializing in developing pharmaceutical products for pain...
SALT LAKE CITY, UT / ACCESSWIRE / March 2, 2020 / Just one experience with KISS frontman Gene Simmons taught a...
FT. MYERS, FL / ACCESSWIRE / March 2, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
Collaboration offers clients increased interoperability and a patient-centered care experience. MADISON, Wis.--(BUSINESS WIRE)--MedBridge, the industry-leading continuing education and patient engagement...
Combination of health intelligence and oncology EMR expertise will give oncologists more real-time patient insights and increased awareness of clinical...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that continuous RRp® (respiration rate from the photoplethysmograph) monitoring of adult and pediatric...
FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory...